People living with rare autoimmune and rheumatic diseases are suffering from ‘alarming’ disparities in the quality of care and treatment they receive, a report has argued, disparities that have only been exacerbated by the pandemic.
The…
Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late 2024 Conference call and webcast today at 5:00 p.m. ET EXTON, Pa. and DURHAM, N.C.,…
Physician’s Briefing Staff
FRIDAY, Sept. 16, 2022 (HealthDay News) -- In new guidelines issued by the American College of Rheumatology, evidence-based recommendations are presented for the use of…
Research led by the University of Otago in New Zealand has uncovered the strongest evidence yet that household overcrowding is a major risk factor for acute rheumatic fever and streptococcal infections of the skin.
Their research is…
Atlanta, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The American College of Rheumatology has issued an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases that includes support for…
A regular, affordable antibiotic treatment significantly reduced the risk of underlying rheumatic heart disease progression in children and adolescents, according to a new study.
The research, led by the Murdoch Children's Research…
Antibiotic prophylaxis for screen-detected latent rheumatic heart disease reduced progression of disease in children, the GOAL trial showed.
Echocardiographic progression was reduced…
Dr. Barbhaiya and her colleagues presented their study, "Risk Factors for 'Long Haul' COVID-19 in Rheumatology Outpatients in New York City," at the American College of Rheumatology (ACR) annual meeting.
…